Clinical Trial Update: High Risk Populations Among COPD Patients in Japan

View source ↗

Summary

A completed clinical trial update from AstraZeneca assessing high-risk populations among patients with chronic obstructive pulmonary disease in Japan.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: AstraZeneca | Conditions: COPD | Status: COMPLETED